Teleflex Incorporated (NYSE:TFX) Shares Purchased by Arizona State Retirement System

Arizona State Retirement System raised its holdings in shares of Teleflex Incorporated (NYSE:TFX) by 1.4% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 13,685 shares of the medical technology company’s stock after buying an additional 190 shares during the period. Arizona State Retirement System’s holdings in Teleflex were worth $2,436,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of TFX. Janus Henderson Group PLC lifted its position in Teleflex by 2.8% during the third quarter. Janus Henderson Group PLC now owns 5,376,452 shares of the medical technology company’s stock valued at $1,329,704,000 after buying an additional 147,147 shares in the last quarter. FMR LLC lifted its position in shares of Teleflex by 70.1% during the third quarter. FMR LLC now owns 269,490 shares of the medical technology company’s stock worth $66,650,000 after purchasing an additional 111,086 shares in the last quarter. Point72 Asset Management L.P. lifted its position in shares of Teleflex by 31.2% during the third quarter. Point72 Asset Management L.P. now owns 407,442 shares of the medical technology company’s stock worth $100,768,000 after purchasing an additional 96,958 shares in the last quarter. Parkman Healthcare Partners LLC acquired a new position in shares of Teleflex during the third quarter worth $23,778,000. Finally, Robeco Institutional Asset Management B.V. lifted its position in shares of Teleflex by 1,401.5% during the fourth quarter. Robeco Institutional Asset Management B.V. now owns 41,726 shares of the medical technology company’s stock worth $7,426,000 after purchasing an additional 38,947 shares in the last quarter. 95.62% of the stock is owned by institutional investors and hedge funds.

Teleflex Stock Down 1.0 %

TFX stock opened at $138.40 on Tuesday. The company has a debt-to-equity ratio of 0.37, a current ratio of 2.42 and a quick ratio of 1.39. Teleflex Incorporated has a 1-year low of $128.55 and a 1-year high of $249.90. The firm has a fifty day moving average price of $170.36 and a two-hundred day moving average price of $200.33. The firm has a market cap of $6.42 billion, a price-to-earnings ratio of 27.51, a PEG ratio of 1.73 and a beta of 1.21.

Teleflex (NYSE:TFX) last released its earnings results on Thursday, February 27th. The medical technology company reported $3.89 earnings per share for the quarter, beating the consensus estimate of $3.86 by $0.03. Teleflex had a net margin of 7.85% and a return on equity of 14.19%. The firm had revenue of $795.40 million during the quarter, compared to analyst estimates of $813.24 million. Research analysts predict that Teleflex Incorporated will post 13.98 EPS for the current year.

Teleflex Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Monday, March 17th. Shareholders of record on Friday, March 7th will be paid a dividend of $0.34 per share. The ex-dividend date is Friday, March 7th. This represents a $1.36 annualized dividend and a yield of 0.98%. Teleflex’s payout ratio is 95.77%.

Analyst Upgrades and Downgrades

TFX has been the topic of a number of recent research reports. Morgan Stanley reduced their target price on shares of Teleflex from $275.00 to $191.00 and set an “overweight” rating on the stock in a research report on Wednesday, March 5th. Truist Financial reduced their target price on shares of Teleflex from $200.00 to $149.00 and set a “hold” rating on the stock in a research report on Monday, March 3rd. Bank of America lowered shares of Teleflex from a “neutral” rating to an “underperform” rating and dropped their price target for the stock from $235.00 to $140.00 in a research note on Tuesday, March 4th. Wells Fargo & Company dropped their price target on shares of Teleflex from $214.00 to $146.00 and set an “equal weight” rating for the company in a research note on Friday, February 28th. Finally, Citizens Jmp lowered shares of Teleflex from an “outperform” rating to a “market perform” rating in a research note on Thursday, February 27th. One analyst has rated the stock with a sell rating, nine have issued a hold rating and two have issued a buy rating to the stock. According to MarketBeat, the stock has an average rating of “Hold” and an average price target of $182.63.

About Teleflex

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.